President Trump Announces Potential 1500% Cut in Drug Prices to Match Europe

WASHINGTON, D.C. — President Donald Trump reiterated his pledge to slash drug prices in the U.S., claiming potential reductions of up to 1,500 percent. Speaking to the press on Sunday, he emphasized the importance of aligning American drug costs with those in Europe. "We aim to match Europe's prices. That's the goal," Trump stated, highlighting that drug prices in the U.S. have remained substantially higher for the past 25 to 30 years. He further claimed, "I took steps to address this last week with a letter. It's hard to see how anyone could win an election opposing this issue." Trump outlined an aggressive timeline, asserting that these price cuts could be achieved within two to three months, with reductions reaching as high as 1,400 to 1,500 percent and at least 500 percent. The President has sent formal correspondence to over a dozen pharmaceutical companies, outlining required measures to lower drug costs domestically, and warned of unspecified consequences if they fail to comply. The debate over drug pricing remains a prominent policy concern, with previous efforts by President Biden to negotiate lower prices. The impact of Trump's latest initiative is yet to be determin...